What's new in stroke? The top 10 studies of 2006-2008. Part II

Robert G Hart1

  • 1Vascular Neurology, Department of Neurology, University of Texas Health Science Center, San Antonio, TX 78229, USA. hartr@uthscsa.edu

Insights

The ABCD2 score predicts stroke risk after transient ischemic attack. High-dose atorvastatin, IV tPA, and warfarin offer stroke prevention and treatment benefits, though carotid stenting

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Clinical Trials

Background:

  • Stroke prevention and treatment are critical public health concerns.
  • Recent clinical trials have aimed to refine management strategies for stroke and transient ischemic attack (TIA).
  • Understanding the efficacy and safety of various interventions is essential for improving patient outcomes.

Purpose of the Study:

  • To review six influential studies from 2006-2008 impacting stroke and TIA clinical management.
  • To summarize key findings regarding stroke risk stratification, prevention, and treatment.

Main Methods:

  • Review of six significant clinical studies published between 2006 and 2008.
  • Analysis of data related to stroke risk scores, pharmacological interventions, and revascularization procedures.

Main Results:

  • The ABCD2 score accurately stratifies 7-day stroke risk post-TIA (high 12%, moderate 6%, low 1%).
  • High-dose atorvastatin reduces recurrent stroke but may increase CNS hemorrhage (SPARCL).
  • Intravenous tissue plasminogen activator benefits selected patients within 3-4.5 hours of ischemic stroke (ECASS III).
  • Adjusted-dose warfarin is superior and safe for elderly atrial fibrillation patients (BAFTA).
  • Optimal role of carotid angioplasty/stenting versus endarterectomy remains uncertain (SAPPHIRE, EVA-3S, SPACE).
  • Enoxaparin is an effective alternative to unfractionated heparin for VTE prevention post-stroke (PREVAIL).

Conclusions:

  • Recent studies provide crucial insights into optimizing stroke prevention and treatment.
  • The ABCD2 score aids in risk stratification for TIA patients.
  • Pharmacological interventions like atorvastatin, tPA, and warfarin have defined roles in stroke management.
  • Further research is needed to clarify the best approach for carotid revascularization.

Related Concept Videos

Stroke: Introduction and Types01:29

Stroke: Introduction and Types

A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...